About one-third of employer health plans now cover the drugs for obesity in addition to diabetes, a jump from 26% in 2023, according to an International Foundation of Employee Benefit Plans survey released in June
There are two approaches, and clinicians disagree about which is better
It appears to protect kidney function by improving blood glucose control, reducing inflammation, and potentially lessening protein loss in urine, which is a key indicator of kidney stress
In this context, heterogeneity should not be dismissed as mere statistical noise
Maintaining achieved results through ongoing treatment becomes the appropriate goal once plateau occurs
Poor techniquesuch as intramuscular injectionmay cause faster absorption and variable blood levels, potentially reducing the sustained appetite suppression that drives weight loss